Podcast Q&A: The Benefits of Linking SDOH with Other Real-World Data
This podcast segment features the Q&A from Magnolia Market Access’ April 6, 2023 webinar with HealthEconomics.Com. In this episode [...]
Podcast Q&A: Improving the Representativeness of Research
This podcast segment features the Q&A from Cardinal Health's March 23, 2023 webinar with HealthEconomics.Com. Join Dr. Bruce Feinberg, Dr. [...]
Podcast Q&A: Literature Reviews and Global Value Dossiers
This podcast segment features the Q&A from DistillerSR’s March 15, 2023 webinar with HealthEconomics.Com. Join Gillian Sibbring, Sue O’Leary, [...]
Podcast Q&A: HEOR for Medical Technologies for the US Healthcare System
This podcast segment features the Q&A from Alira Health's December 14, 2022 webinar and features Deepak Sahu, MBA, MPH [...]
Podcast Q&A: Designing Causal Inference Studies Using Real-World Data
This podcast segment features the Q&A from HealthCore's December 7, 2022 webinar and features an expert panel including Michael [...]
Podcast Q&A: Achieving Consensus When Everyone is an Expert, but No One Agrees
This podcast segment features the Q&A from PHAR's October 25, 2022 webinar and features an expert panel including Jincy [...]
Podcast Q&A: Social Media Data: Opportunities and Insights for Clinical Research
This tHEORetically Speaking podcast segment highlights the Q&A from ICON's November 30, 2022 webinar and features an expert panel, [...]
Podcast Q&A: Making HEOR More Accessible to Patients
This podcast segment features the Q&A from OPEN Health's October 13, 2022 webinar and features an expert panel, including Danielle [...]
Podcast Q&A: An Introduction to Infectious Disease Modeling
This podcast segment from ICON's September 29, 2022 webinar features the Q&A with Marija Zivkovic-Gojovic, Richard Pitman, and Pragya Khurana [...]
Podcast Q&A: Streamlining Health Technology Assessments by Automating Literature Reviews
This podcast segment features the Q&A from DistillerSR's November 17, 2022 webinar and features a panel of experts, including Chris [...]
Podcast Q&A: Advancing Patient Care through Real-World Data, Machine Learning, and Systems Biology
This podcast segment from Syapse's September 21, 2022 webinar features the Q&A with Nitin Baliga, Insitute of Systems Biology, and [...]
Podcast Q&A: Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
This tHEORetically Speaking podcast episode highlights the Q&A from Genesis Research's October 20, 2022 webinar and features Priti Jhingran and [...]
Podcast: How Accelerated Drug Development Requires Disruption in Market Access and Pricing
We recently sat down with Preeti Patel, MPharm, CEO and Founder of Global Pricing Innovations (GPI), to learn what is [...]
How might digitization change health care in Germany by 2035, Julian Molitor?
Digital health could improve the efficiency, care and way patients are treated in all health care systems in the next [...]
Are selective contracts with German insurances a smarter reimbursement pathway, Tim Hering?
Within the opportunity of contracting in the German health care market, prices, reimbursement and integrated care paths could be agreed [...]
Would AI substitute or (only) support market access managers, Dr. Andree Bates?
Dr Stefan Walzer, market access expert, and his guest Dr. Andree Bates, expert in artificial intelligence (AI), are discussing the future [...]
Podcast Q&A: Evidence Generation Planning
This podcast segment from Syneos Health's July 26, 2022 webinar features the Q&A with Colin Oliver, Anila Dede, Erwin De [...]
How successful is the DiGA fast track, Dr. Henrik Matthies?
Dr. Matthies used to be at the epicenter of the DIGA launch in 2020. He was the managing director of [...]
The UK market access has always been complex, now even more than before, Graham Foxon and Paul Craddy?
The UK has always been on the forefront of market access with its unique pathways within England, but especially also considering Wales, [...]
Switzerland is strong in many aspects, so also in its health care system, Dr. Peter Indra?
The Swiss healthcare system is rather complex but at the same time quite effective. High expenditures into health care corresponds with [...]
Podcast Q&A: Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations
This podcast segment from Self Care Catalysts' June 29, 2022 webinar features the Q&A with Renee Willmon, MSc, Senior Director, [...]
Podcast Q&A: Understanding Health Care Decision Maker Preferences for Optimized Engagement
This podcast segment from ICON's June 23, 2022 webinar features the Q&A with panel participants as they discussed best practices [...]
What is the secret of the cost-efficient healthcare system in Israel, Mirel Stelian?
Israel spends only 7.6% of the GDP on healthcare – significantly less than most other Western OECD countries. At the [...]
Dutch payers are pragmatic, especially when discussing medical devices, isn’t it, Ron de Graff?
The market access process in the Netherlands can be very special, especially for medical devices. Besides standard reimbursement processes with [...]
Podcast Q&A: FDA Guidance Documents: Shaping the Future of RWD Curation and RWE Innovation
This podcast segment features the Q&A from IQVIA's May 25, 2022 webinar hosted IQVIA experts Raina Olexa, Senior Principal Scientist [...]
